Cobra Biologics Appoints CSO
This article was originally published in Scrip
International contract manufacturing organization Cobra Biologics has named Dr Daniel C Smith chief scientific officer. He will be responsible for enhancing Cobra's DNA, virus, microbial and mammalian proteins research and development platforms. Prior to joining the Sweden and UK-situated company Dr Smith was a knowledge transfer manager with bioProcessUK at the HealthTech and Medicines Knowledge Transfer Network.